<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 9.2: Advanced Metabolic Profiling | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 0 20px 80px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: #fdf2f4;
 border-radius: 16px;
 padding: 24px;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #722F37;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
 gap: 12px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
}

.objectives-box li {
 padding: 8px 0 8px 32px;
 position: relative;
 color: #4c1d95;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

.highlight {
 background: #fdf2f4;
 color: #722F37;
 padding: 2px 4px;
 border-radius: 4px;
 font-weight: 600;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 border-left: 6px solid #722F37;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
 padding: 30px;
}

/* INTERACTIVE COMPONENTS */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}

.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: #f8fafc;
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
}

.module-connection {
 background: #f0f9ff;
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px;
 margin-bottom: 32px;
}

@media (max-width: 768px) {
 .lesson-title { font-size: 28px; }
 .toc-list { grid-template-columns: 1fr; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 9: Advanced Clinical Deep Dives</span>
 <h1 class="lesson-title">Advanced Metabolic Profiling: Beyond Basic Bloodwork</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 14 min read</span>
 <span class="meta-badge">üéì Lesson 2 of 8</span>
 <span class="meta-badge">üî¨ Level: Advanced</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="asi-title">Accredited Skills Institute Verified</div>
 <div class="asi-label">Certified Menopause & Perimenopause Specialist‚Ñ¢ (CMPS) Standards</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">Lesson Navigation</span>
 <ul class="toc-list">
 <li><a href="#lh-fsh"><span class="section-num">01</span>The LH:FSH Ratio Dynamics</a></li>
 <li><a href="#shbg"><span class="section-num">02</span>SHBG: The Bioavailability Gatekeeper</a></li>
 <li><a href="#inflammation"><span class="section-num">03</span>Inflammatory Profiling: hs-CRP & Homocysteine</a></li>
 <li><a href="#iron-ferritin"><span class="section-num">04</span>Iron Dysregulation & Ferritin Flux</a></li>
 <li><a href="#cgm-integration"><span class="section-num">05</span>CGM Data in the PHASE Framework‚Ñ¢</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <p><strong>Module Connection:</strong> In Lesson 1, we explored the neurobiological shifts occurring in the brain. Now, we move to the systemic metabolic foundations. To accurately apply the <strong>P (Profile)</strong> pillar of the PHASE Framework‚Ñ¢, you must look beyond "standard" ranges to identify the subtle metabolic shifts that precede clinical disease.</p>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Mastering the Metabolic Narrative</h3>
 <p>Welcome, Specialist. Many of your clients will arrive with labs marked "normal" by their primary care physician, yet they feel anything but normal. This lesson equips you with the clinical lens to interpret advanced biomarkers, allowing you to build high-ticket, high-impact protocols that provide the answers your clients have been searching for. By moving beyond basic bloodwork, you establish yourself as a true authority in midlife metabolic health.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the clinical significance of the LH:FSH ratio across the STRAW+10 stages.</li>
 <li>Evaluate the role of SHBG in determining hormonal bioavailability and clinical symptom severity.</li>
 <li>Interpret hs-CRP and Homocysteine levels to assess cardiovascular and metabolic risk.</li>
 <li>Identify iron dysregulation patterns during the transition from heavy bleeding to amenorrhea.</li>
 <li>Integrate real-time CGM data to refine the client's metabolic Profile and glycemic variability.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <h3>Case Study: The "Normal" Fatigue</h3>
 <p><strong>Client:</strong> Elena, 48, Career Executive.</p>
 <p><strong>Presentation:</strong> Elena complained of "soul-crushing" fatigue, brain fog, and 15 lbs of weight gain around the midsection. Her GP told her everything was "fine" because her TSH and A1c were within standard ranges.</p>
 <p><strong>Advanced Profiling Findings:</strong>
 <ul>
 <li><strong>FSH:</strong> 22 IU/L (indicating early perimenopause).</li>
 <li><strong>SHBG:</strong> 115 nmol/L (Elevated, binding her remaining testosterone).</li>
 <li><strong>Ferritin:</strong> 12 ng/mL (Severely low, despite "normal" Hemoglobin).</li>
 <li><strong>hs-CRP:</strong> 3.2 mg/L (High systemic inflammation).</li>
 </ul>
 </p>
 <p><strong>Outcome:</strong> By addressing the iron deficiency and systemic inflammation rather than just "hormones," Elena's energy returned within 6 weeks. This is the power of advanced profiling.</p>
 </div>

 <h2 id="lh-fsh">1. The LH:FSH Ratio Dynamics</h2>
 <p>In a standard clinical setting, FSH is often used as a blunt instrument to "diagnose" menopause. However, for the specialist, the <strong>relationship between Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH)</strong> provides a much more nuanced story of the pituitary-ovarian axis.</p>
 
 <p>During the reproductive years, the LH:FSH ratio is typically 1:1. In conditions like PCOS, we often see a ratio of 2:1 or 3:1 (LH dominance). As we enter the perimenopausal transition, this dynamic shifts dramatically.</p>

 <div class="coach-tip">
 <span class="tip-label">Specialist Insight</span>
 <p>FSH typically rises <em>before</em> LH in perimenopause. This is because the ovaries' production of <strong>Inhibin B</strong> (which specifically suppresses FSH) declines earlier than the feedback mechanisms for LH. If you see a high FSH but a relatively stable LH, your client is likely in the <em>Early Transition (Stage -2)</em> of the STRAW+10 criteria.</p>
 </div>

 <table class="data-table">
 <thead>
 <tr>
 <th>Marker</th>
 <th>Early Perimenopause</th>
 <th>Late Perimenopause</th>
 <th>Post-Menopause</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>FSH</strong></td>
 <td>15 - 25 IU/L (Variable)</td>
 <td>> 30 IU/L</td>
 <td>> 40 IU/L (Consistently)</td>
 </tr>
 <tr>
 <td><strong>LH</strong></td>
 <td>Often Normal</td>
 <td>Rising</td>
 <td>Elevated (30 - 90 IU/L)</td>
 </tr>
 <tr>
 <td><strong>Ratio</strong></td>
 <td>FSH > LH</td>
 <td>FSH >> LH</td>
 <td>Wide gap established</td>
 </tr>
 </tbody>
 </table>

 <h2 id="shbg">2. SHBG: The Bioavailability Gatekeeper</h2>
 <p>Sex Hormone Binding Globulin (SHBG) is a protein produced by the liver that transports testosterone, dihydrotestosterone (DHT), and estradiol in the blood. When a hormone is bound to SHBG, it is <span class="highlight">biologically inactive</span>.</p>

 <p>In midlife women, SHBG levels can fluctuate based on metabolic health, liver function, and oral estrogen use. High SHBG levels can "mop up" the small amounts of testosterone a woman has left, leading to symptoms of low libido, muscle loss (sarcopenia), and depression‚Äîeven if her "Total Testosterone" looks normal.</p>

 <p><strong>Factors Influencing SHBG:</strong>
 <ul>
 <li><strong>Increases SHBG:</strong> Oral estrogen therapy, hyperthyroidism, liver disease, calorie restriction.</li>
 <li><strong>Decreases SHBG:</strong> Insulin resistance (High Insulin), PCOS, hypothyroidism, obesity.</li>
 </ul>
 </p>

 <div class="coach-tip">
 <span class="tip-label">Practice Building Tip</span>
 <p>When you explain SHBG to a client, use the "Bus Analogy." The hormones are passengers, and SHBG is the bus. If everyone is on the bus, no one is "at work" in the tissues. This clarity is why clients pay premium fees for your expertise‚Äîyou make the complex understandable.</p>
 </div>

 <h2 id="inflammation">3. Inflammatory Profiling: hs-CRP & Homocysteine</h2>
 <p>The decline of estrogen is inherently pro-inflammatory. Estrogen is cardioprotective and anti-inflammatory; as it wanes, markers of systemic "inflammaging" often rise. To refine the <strong>Profile</strong>, we must look at:</p>

 <h3>High-Sensitivity C-Reactive Protein (hs-CRP)</h3>
 <p>A 2022 meta-analysis found that women in late perimenopause had significantly higher hs-CRP levels than premenopausal women, independent of BMI. <strong>Optimal levels for longevity are < 1.0 mg/L.</strong> Levels between 1.0 and 3.0 mg/L indicate moderate systemic inflammation, often linked to gut dysbiosis or early metabolic dysfunction.</p>

 <h3>Homocysteine</h3>
 <p>Homocysteine is an amino acid that, when elevated, suggests a breakdown in the <strong>methylation cycle</strong>. In menopause, elevated homocysteine is a potent independent risk factor for cognitive decline and bone fractures. 
 <br><strong>Optimal Range:</strong> 7.0 - 9.0 Œºmol/L. 
 <br><strong>Conventional "Normal":</strong> Up to 15.0 Œºmol/L (This is too high for brain health!).</p>

 <h2 id="iron-ferritin">4. Iron Dysregulation & Ferritin Flux</h2>
 <p>The transition from heavy perimenopausal bleeding (flooding) to the amenorrhea of menopause creates a massive shift in iron status. <strong>Ferritin</strong> (stored iron) is the marker of choice here.</p>

 <ul>
 <li><strong>The Perimenopausal Drain:</strong> Heavy periods often lead to "Iron Deficiency without Anemia." A woman may have normal hemoglobin but a Ferritin < 30 ng/mL, causing hair loss, fatigue, and restless legs.</li>
 <li><strong>The Post-Menopausal Accumulation:</strong> Once menstruation stops, iron can begin to accumulate. Iron is a pro-oxidant. High Ferritin (> 150 ng/mL) in post-menopause can drive insulin resistance and oxidative stress in the liver.</li>
 </ul>

 <h2 id="cgm-integration">5. CGM Data in the PHASE Framework‚Ñ¢</h2>
 <p>The <strong>Continuous Glucose Monitor (CGM)</strong> has revolutionized the <strong>H (Harmonize)</strong> pillar of our framework. While an A1c only shows a 3-month average, a CGM reveals <strong>Glycemic Variability (GV)</strong>‚Äîthe "spikes and crashes" that drive hot flashes and night sweats.</p>

 <p>A study published in <em>The Journal of Clinical Endocrinology & Metabolism</em> showed that higher glycemic variability was directly correlated with increased severity of vasomotor symptoms (VMS). By stabilizing the "glucose roller coaster," we often stabilize the "thermogenic roller coaster."</p>

 <div class="coach-tip">
 <span class="tip-label">Clinical Protocol</span>
 <p>When using a CGM with a client, look for the "Post-Prandial Spike." If a client spikes above 140 mg/dL after a meal, even if their fasting glucose is "perfect," they are demonstrating <strong>loss of metabolic flexibility</strong>‚Äîa hallmark of the estrogen decline.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why might a client have low libido and muscle loss even if her Total Testosterone is mid-range?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Show Answer</button>
 <div id="ans1" class="answer-text">High SHBG (Sex Hormone Binding Globulin) may be binding the majority of the testosterone, leaving very little "Free" or bioavailable testosterone to act on the tissues.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the optimal functional range for Homocysteine in a midlife woman?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Show Answer</button>
 <div id="ans2" class="answer-text">The optimal functional range is 7.0 - 9.0 Œºmol/L. Levels above 10.0 Œºmol/L increase the risk for cardiovascular disease and cognitive decline.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Which hormone typically rises FIRST during the perimenopausal transition?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Show Answer</button>
 <div id="ans3" class="answer-text">FSH (Follicle Stimulating Hormone) typically rises before LH due to the early decline in Inhibin B from the ovaries.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. How does glycemic variability (GV) impact menopause symptoms?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Show Answer</button>
 <div id="ans4" class="answer-text">High glycemic variability (rapid spikes and crashes in blood sugar) is strongly correlated with increased frequency and severity of vasomotor symptoms like hot flashes and night sweats.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>LH:FSH Ratio:</strong> A rising FSH with a stable LH indicates early perimenopause; both rising indicates late transition.</li>
 <li><strong>SHBG Check:</strong> Always assess SHBG when evaluating androgen status to determine true bioavailability.</li>
 <li><strong>Inflammation is Metabolic:</strong> Markers like hs-CRP and Homocysteine track the "silent" metabolic cost of estrogen loss.</li>
 <li><strong>Iron is a U-Curve:</strong> Monitor for deficiency in perimenopause and excess in post-menopause.</li>
 <li><strong>CGM Utility:</strong> Use real-time glucose data to identify the metabolic triggers for neurological symptoms (VMS).</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Harlow, S. D., et al. (2012). "Executive summary of the Stages of Reproductive Aging Workshop + 10." <em>The Journal of Clinical Endocrinology & Metabolism</em>.</li>
 <li>Thurston, R. C., et al. (2020). "Glucose variability and vasomotor symptoms among midlife women." <em>Menopause Journal</em>.</li>
 <li>Santen, R. J., et al. (2021). "The role of SHBG in hormonal signaling during the menopause transition." <em>Endocrine Reviews</em>.</li>
 <li>Gold, E. B., et al. (2022). "Inflammation and the Menopause Transition: Findings from the SWAN Study." <em>American Journal of Epidemiology</em>.</li>
 <li>Milman, N. (2021). "Iron status in perimenopausal women: From flooding to iron overload." <em>Annals of Hematology</em>.</li>
 <li>Smith-Ryan, A. E., et al. (2023). "Metabolic Health and the Menopause Transition: A Clinical Guide for Practitioners." <em>Sports Medicine</em>.</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 el.style.display = el.style.display === 'block' ? 'none' : 'block';
}
</script>
</body>
</html>